About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 131 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 131 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 131 trials

CompletedStudy to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I DisorderThis study will evaluate the effect of ALKS 3831 compared to olanzapine on body weight in young adults with schizophrenia, schizophreniform, or bipolar I disorder who are early in…NCT03187769·Little Rock, Arkansas and 56 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingEnhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.NCT06345963·Houston, Texas

CompletedMonotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode SchizophreniaThe purpose of this study is to investigate the effects of flexibly dosed Brexpiprazole monotherapy in the improvement of early-episode schizophrenia through the assessment of…NCT02013622·Cerritos, California and 21 others

CompletedA Comparison of Seroquel vs. Risperidone in SchizophreniaThe purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.NCT00034905·Birmingham, Alabama and 63 others

CompletedOpen-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum DisorderThe purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizophrenia, bipolar I disorder, or…NCT04578756·Dothan, Alabama and 41 others

CompletedStudy Evaluating Vabicaserin in Subjects With SchizophreniaThe primary purpose of this protocol is to establish the efficacy, safety, and tolerability of vabicaserin (SCA-136) using a once a day capsule in subjects with acute…NCT00563706·Little Rock, Arkansas and 32 others

CompletedOpen-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleThe purpose of this study is to compare retrospective hospitalization rates of schizophrenic patients treated with oral antipsychotics to prospective hospitalization rates of…NCT01432444·Dothan, Alabama and 123 others

CompletedA Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02873208·Little Rock, Arkansas and 44 others

CompletedEffects of Cariprazine on Cardiac Repolarization in Patients With SchizophreniaThis study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.NCT01376076·Glendale, California and 3 others

TerminatedA Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of SchizophreniaThis study is examining the efficacy of PF-03463275 compared to placebo in treating negative symptoms of schizophrenia when added to ongoing antipsychotic treatment in stable…NCT00977522·Cerritos, California and 36 others

CompletedA Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaThis is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.NCT01678755·Chino, California and 19 others

CompletedOlanzapine Versus An Active Comparator in the Treatment of SchizophreniaThe purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophreniaNCT00036088·El Centro, California and 59 others

CompletedBrexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentTo investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in active adults with MDD, 18 to 35 years old, who are experiencing an inadequate…NCT02013609·Cerritos, California and 23 others

CompletedThe Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderOlanzapine is currently marketed for the treatment of schizophrenia and acute manic episodes with bipolar 1 disorder.NCT00044187·El Centro, California and 15 others

TerminatedStudy Evaluating Bifeprunox in Patients With Schizophrenia.An open-label extension study using a variable dose (20 to 30 mg daily) of bifeprunox to evaluate long-term safety.NCT00366327·Little Rock, Arkansas and 81 others

CompletedA Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of SchizophreniaThe purpose of this study is to evaluate the efficacy, safety and tolerability of TAK-063 compared with placebo in treatment of acutely exacerbated schizophrenia.NCT02477020·Springdale, Alaska and 14 others

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others

TerminatedA Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX StudyThis study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013).NCT05211947·Anaheim, California and 302 others

CompletedClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning.NCT04846868·Garden Grove, California and 115 others

CompletedA Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaThe objective of this study is to evaluate the efficacy and safety of cariprazine relative to placebo in the prevention of relapse of symptoms in participants with schizophrenia.NCT01412060·Little Rock, Arkansas and 72 others

PreviousPage 5 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia